Agenda
Virtual Meeting Agenda | February 7 - 8, 2023
(Please note, the following times are approximate and all times are ET)
| Tuesday, February 7 | ||
| 12:00 - 12:10 p.m. | Introduction and opening remarks | Dr. Katrina Goddard, Director, Division of Cancer Control and Population Sciences, NCI |
| 12:10 - 12:30 p.m. |
When is a variant truly characterized? |
Dr. Alvaro Monteiro, Session Organizer, Moffitt Cancer Center |
| 12:30 - 12:50 p.m. |
Developing and standardizing variant to biology databases and computational tools |
Dr. Alexander Gusev, Session Organizer, Dana-Farber/ Harvard Cancer Center |
| 12:50 - 1:10 p.m. |
Optimization, adoption, and implementation of high throughput assays |
Dr. Kevin Brown, Session Organizer, Division of Cancer Epidemiology and Genetics, NCI Dr. Doug Fowler, University of Washington |
| 1:10 - 1:40 p.m. | Break | |
| 1:40 - 1:45 p.m. | Instructions for Breakout sessions | |
| 1:45 - 3:00 p.m. |
Breakout sessions
|
|
| 3:00 - 3:15 p.m. | Break | |
| 3:15 - 4:15 p.m. |
Report back and discussion |
|
| Wednesday, February 8 | ||
| 12:00 - 12:20 p.m. |
Considerations for use of models for understanding variant function |
Dr. Amanda Toland, Session Organizer, The Ohio State University Comprehensive Cancer Center Dr. Li Yi, Bayor College of Medicine |
| 12:20 - 12:40 p.m. |
Creating and improving large multidisciplinary collaborations |
Dr. Lea Starita, Session Organizer, University of Washington Dr. Mike Pazin, National Human Genome Research Institute |
| 12:40 - 1:00 p.m. |
Diversity in data and assays |
Dr. Alvaro Monteiro, Session Organizer, Moffitt Cancer Center Dr. Luis Carvajal-Carmona, UC Davis Comprehensive Cancer Center |
| 1:00 - 1:30 p.m. | Break | |
| 1:30 - 2:45 p.m. |
Breakout sessions:
|
|
| 2:45 - 3:05 p.m. | Break | |
| 3:05 - 3:50 p.m. |
Report back and discussion |
|
| 3:50 - 4:00 p.m. |
Closing remarks |
Dr. Stephen Chanock, Director, Division of Cancer Epidemiology and Genetics, NCI |